Real-World Data on Potent P2Y12 Inhibition in Patients with Suspected Chronic Coronary Syndrome, Referred for Coronary Angiography

INTRODUCTION: Potential benefit with potent platelet inhibition in patients with chronic coronary syndrome (CCS) undergoing percutaneous coronary intervention (PCI) has been discussed. The aim of this study was to compare a potent P2Y12 inhibition strategy using ticagrelor with clopidogrel in CCS pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Träff, Erik, Venetsanos, Dimitrios, Alpkvist, Karin, Sederholm Lawesson, Sofia, Skibniewski, Mikolaj, Zwackman, Sammy, Alfredsson, Joakim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
CAD and AMI: Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808708/
https://www.ncbi.nlm.nih.gov/pubmed/36215960
http://dx.doi.org/10.1159/000527459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808708/
https://www.ncbi.nlm.nih.gov/pubmed/36215960
http://dx.doi.org/10.1159/000527459

Ejemplares similares